One Charles Private Wealth Services LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 670 shares of the healthcare conglomerate’s stock, valued at approximately $268,000.
Several other institutional investors have also made changes to their positions in UNH. OLD Mission Capital LLC purchased a new stake in shares of UnitedHealth Group during the third quarter worth $439,000. Camden National Bank increased its holdings in UnitedHealth Group by 5.5% in the fourth quarter. Camden National Bank now owns 1,902 shares of the healthcare conglomerate’s stock valued at $667,000 after buying an additional 100 shares during the last quarter. Signet Financial Management LLC acquired a new position in UnitedHealth Group in the first quarter valued at $277,000. Unigestion Holding SA boosted its stake in UnitedHealth Group by 52.6% in the first quarter. Unigestion Holding SA now owns 1,778 shares of the healthcare conglomerate’s stock valued at $662,000 after acquiring an additional 613 shares in the last quarter. Finally, Avidian Wealth Solutions LLC boosted its stake in shares of UnitedHealth Group by 9.6% during the first quarter. Avidian Wealth Solutions LLC now owns 1,801 shares of the healthcare conglomerate’s stock worth $670,000 after buying an additional 158 shares during the period. Hedge funds and other institutional investors own 86.21% of the company’s stock.
UNH has been the subject of several recent research reports. Cowen initiated coverage on shares of UnitedHealth Group in a research note on Thursday, September 9th. They set an “outperform” rating and a $478.00 target price for the company. Barclays raised their price objective on shares of UnitedHealth Group from $435.00 to $465.00 and gave the company an “overweight” rating in a research report on Friday, July 16th. Stephens raised their price objective on shares of UnitedHealth Group from $440.00 to $460.00 and gave the company an “overweight” rating in a research report on Friday, July 16th. Wells Fargo & Company initiated coverage on shares of UnitedHealth Group in a research report on Monday, May 24th. They issued an “overweight” rating and a $478.00 price objective for the company. Finally, Truist Securities raised their price objective on shares of UnitedHealth Group from $480.00 to $500.00 and gave the company a “buy” rating in a research report on Friday, July 16th. Three equities research analysts have rated the stock with a hold rating, twenty have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and an average price target of $444.04.
Shares of UNH traded up $3.03 during mid-day trading on Wednesday, reaching $415.57. The company had a trading volume of 10,078 shares, compared to its average volume of 2,983,495. The stock has a market cap of $391.85 billion, a price-to-earnings ratio of 27.25, a price-to-earnings-growth ratio of 1.62 and a beta of 0.77. The firm has a fifty day simple moving average of $416.16 and a 200-day simple moving average of $398.29. UnitedHealth Group Incorporated has a fifty-two week low of $289.64 and a fifty-two week high of $431.36. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.62.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Wednesday, July 14th. The healthcare conglomerate reported $4.70 earnings per share for the quarter, beating the Zacks’ consensus estimate of $4.43 by $0.27. The company had revenue of $71.32 billion for the quarter, compared to analyst estimates of $69.51 billion. UnitedHealth Group had a net margin of 5.33% and a return on equity of 22.15%. UnitedHealth Group’s revenue for the quarter was up 14.8% on a year-over-year basis. During the same quarter last year, the business earned $7.12 EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 18.74 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 21st. Investors of record on Monday, September 13th will be issued a dividend of $1.45 per share. The ex-dividend date of this dividend is Friday, September 10th. This represents a $5.80 annualized dividend and a dividend yield of 1.40%. UnitedHealth Group’s payout ratio is 34.36%.
UnitedHealth Group Profile
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.
Featured Story: What is intrinsic value?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.